Product
Dorzagliatin
3 clinical trials
3 indications
Indication
PatientIndication
Diabetic Nephropathy Type 2Indication
Type 2 DiabetesClinical trial
A Phase 1, Open-Label, Sequential, Multiple-Dose, Drug-Drug Interaction Study of Dorzagliatin and Sitagliptin in Subjects With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2019-08-30
Clinical trial
A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.Status: Not yet recruiting, Estimated PCD: 2025-05-31
Clinical trial
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity on Endogenous Glucose Production in Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2024-09-30